SALT LAKE CITY (AP) -- Utah will receive $8.5 million from a drugmaker accused of making misleading claims about a new drug for diabetes.
GlaxoSmithKline admitted no wrongdoing in agreeing to settle a lawsuit filed by the Utah Attorney General's Office.
The Utah Attorney General's Office alleged GlaxoSmithKline marketed Avandia nationwide as a "wonder drug" offering a "significant advance" in diabetes treatment, despite evidence it increases the risk of heart attacks for certain users.
Assistant Attorney General Robert Morton represented the state in the negotiations with help from private law firms.
The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.